FDA Times Patent for TOPS Posterior Spine Gadget
Published Date: 7/2/2025
Notice
Summary
The FDA has set the official review period for the TOTAL POSTERIOR SPINE SYSTEM (TOPS SYSTEM), a medical device. This helps the company extend its patent, giving them more time to protect their invention. If you’re in the medical or patent world, this means the device’s makers get extra time before others can copy it, potentially affecting market timing and profits.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Patent Extension for TOPS System
The FDA has determined the regulatory review period for the TOTAL POSTERIOR SPINE SYSTEM (TOPS SYSTEM). This determination supports the device maker’s application to the U.S. Patent and Trademark Office for a patent-term extension, giving the company extra time to exclude competitors from using that medical device.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in